The frequency of tumor infiltrating CD8+ CTLs in the FK@IQ-4T1+L group was 21.8-fold higher that of the PBS control, and 3.4-fold higher than that of the FK@IQ-4T1 group (Fig. 5c). This evidence concerns the gene CD8A and neoplasm.